PTC THERAPEUTICS, INC.

PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070081

Price chart

Open-market purchases and sales by PTCT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 18, 20265:20 PM ETSep 16 – Sep 17, 2026SCHMERTZLER MICHAELDirectorSSaleCommon Stock−20K$67.4864−$1.35M1.3M−1.5%SEC10b5-1
Sep 11, 20265:20 PM ETSep 9 – Sep 10, 2026SCHMERTZLER MICHAELDirectorSSaleCommon Stock−20K$67.5902−$1.35M1.32M−1.5%SEC10b5-1
Aug 28, 20265:20 PM ETAug 26 – Aug 27, 2026SCHMERTZLER MICHAELDirectorSSaleCommon Stock−25K$72.2604−$1.81M1.34M−1.8%SEC10b5-1
Aug 21, 20265:20 PM ETAug 19 – Aug 20, 2026SCHMERTZLER MICHAELDirectorSSaleCommon Stock−25K$72.2165−$1.81M1.36M−1.8%SEC10b5-1
Aug 19, 20265:20 PM ETAug 17, 2026Boulding Mark ElliottEXEC. VP AND CLOSSaleCommon Stock−2.81K$72.5657−$204.13K105.27K−2.6%SEC10b5-1

The largest institutional positions in PTCT at the end of Q2 2026.

Institutions holding PTCT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.13,964,554$1.14B0.02%+1,015,837+7.8%Added
RTW INVESTMENTS, LP7,746,415$631.88M5.39%00.0%Unchanged
Jupiter Topco LLC7,236,402$590.18M0.24%+7,236,402New
VANGUARD PORTFOLIO MANAGEMENT LLC4,928,111$401.99M0.02%+123,517+2.6%Added
STATE STREET CORP4,598,952$375.14M0.01%+252,433+5.8%Added